Biltmore Family Office, LLC Abb Vie Inc. Transaction History

Biltmore Family Office, LLC

$566 Million
Q3 2024

A detailed history of Biltmore Family Office, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Biltmore Family Office, LLC holds 32,171 shares of ABBV stock, worth $5.46 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares

32,171

Previous 31,612 1.77%

Holding current value

$5.46 Million

Previous $5.42 Million 17.17%

% of portfolio

1.12%

Previous 1.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $91,586 - $111,425	559 Added 1.77%	32,171 $6.35 Million
Q2 2024 Aug 07, 2024	BUY	$154.79 - $180.76 $263,143 - $307,292	1,700 Added 5.68%	31,612 $5.42 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $63,928 - $72,840	-400 Reduced 1.32%	29,912 $5.45 Million
Q2 2023 Aug 07, 2023	SELL	$132.51 - $164.9 $11,263 - $14,016	-85 Reduced 0.28%	30,312 $4.08 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $334,627 - $385,373	-2,314 Reduced 7.07%	30,397 $4.84 Million
Q4 2022 Feb 07, 2023	SELL	$138.31 - $165.87 $20,884 - $25,046	-151 Reduced 0.46%	32,711 $5.29 Million
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $40,799 - $46,794	-304 Reduced 0.92%	32,862 $4.41 Million
Q2 2022 Aug 04, 2022	SELL	$137.62 - $174.96 $18,165 - $23,094	-132 Reduced 0.4%	33,166 $5.08 Million
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $1.1 Million - $1.36 Million	-8,323 Reduced 20.0%	33,298 $5.4 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $86,158 - $109,015	802 Added 1.96%	41,621 $5.64 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $610,523 - $693,035	5,738 Added 16.36%	40,819 $4.4 Million
Q2 2021 Jul 30, 2021	BUY	$105.21 - $117.21 $37,559 - $41,843	357 Added 1.03%	35,081 $3.95 Million
Q1 2021 May 12, 2021	SELL	$102.3 - $112.62 $194,267 - $213,865	-1,899 Reduced 5.19%	34,724 $3.76 Million
Q4 2020 Feb 09, 2021	SELL	$80.49 - $108.67 $685,050 - $924,890	-8,511 Reduced 18.86%	36,623 $3.92 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $442,092 - $518,871	-5,146 Reduced 10.23%	45,134 $3.95 Million
Q2 2020 Aug 05, 2020	SELL	$73.37 - $98.18 $282,694 - $378,287	-3,853 Reduced 7.12%	50,280 $4.94 Million
Q1 2020 May 08, 2020	BUY	$64.5 - $97.79 $22,704 - $34,422	352 Added 0.65%	54,133 $4.12 Million
Q4 2019 Feb 05, 2020	BUY	$72.13 - $90.25 $8,222 - $10,288	114 Added 0.21%	53,781 $4.76 Million
Q3 2019 Oct 16, 2019	BUY	$62.98 - $75.72 $125,960 - $151,440	2,000 Added 3.87%	53,667 $4.06 Million
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $44,997 - $55,493	578 Added 1.13%	51,667 $4.76 Million
Q3 2018 Oct 30, 2018	SELL	$88.91 - $98.84 $23,116 - $25,698	-260 Reduced 0.51%	51,089 $4.83 Million
Q2 2018 Jul 17, 2018	SELL	$89.78 - $106.23 $338,470 - $400,487	-3,770 Reduced 6.84%	51,349 $4.76 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $136,634 - $182,966	1,485 Added 2.77%	55,119 $5.22 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $4.8 Million - $5.27 Million	53,634	53,634 $5.19 Million

Others Institutions Holding ABBV

# of Institutions

3,837

Shares Held

1.25B

Call Options Held

15.7M

Put Options Held

11.3M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $300B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Biltmore Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Biltmore Family Office, LLC with notifications on news.

Account

Biltmore Family Office, LLC Abb Vie Inc. Transaction History